| [1] |
WONG B, DICKIE G, GARCIA P, et al. 124I-PET/CT-guided diagnosis and personalized treatment of metastatic papillary thyroid cancer to the pancreas[J]. Clin Nucl Med, 2021, 46(4): 337-339. DOI: 10.1097/RLU.0000000000003499. |
| [2] |
MALEK B, SAIDA S, OLFA J, et al. The management of pancreatic metastasis from synovial sarcoma of the soft tissue: A case report[J]. Rare Tumors, 2020, 12: 2036361320983691. DOI: 10.1177/2036361320983691. |
| [3] |
ADSAY NV, ANDEA A, BASTURK O, et al. Secondary tumors of the pancreas: An analysis of a surgical and autopsy database and review of the literature[J]. Virchows Arch, 2004, 444(6): 527-535. DOI: 10.1007/s00428-004-0987-3. |
| [4] |
LIU AL, FENG YL, ZHAO Y, et al. Pancreatic metastasis from small cell neuroendocrine carcinoma admixed with squamous carcinoma of the uterine cervix: Report of a case and review of literature[J]. Chin J Gastroenterol, 2018, 23(10): 638-639. DOI: 10.3969/j.issn.1008-7125.2018.10.014. |
| [5] |
MORI Y, KIDA Y, MATSUSHITA Y, et al. Neuroendocrine carcinoma of uterine cervix: Stereotactic radiotherapy for brain metastasis and stereotactic body radiotherapy for renal and pancreatic metastases[J]. Cureus, 2020, 12(6): e8869. DOI: 10.7759/cureus.8869. |
| [6] |
KIM DJ, PARK JM, KIM JH, et al. Pancreatic metastasis from adenocarcinoma of the uterine cervix[J]. Korean J Gastroenterol, 2019, 73(3): 182-185. DOI: 10.4166/kjg.2019.73.3.182. |
| [7] |
MANUEL V, ROCHA E, FORTINI G, et al. Uterine cancer presenting as obstructive jaundice[J]. Int J Womens Health, 2016, 8: 261-263. DOI: 10.2147/IJWH.S108587. |
| [8] |
LE LARGE T, MEIJER LL, PALECKYTE R, et al. Combined expression of plasma thrombospondin-2 and CA19-9 for diagnosis of pancreatic cancer and distal cholangiocarcinoma: A proteome approach[J]. Oncologist, 2020, 25(4): e634, e643. DOI: 10.1634/theoncologist.2019-0680. |
| [9] |
FANG X, BIAN Y, WANG L, et al. Significance and differential diagnosis of pancreatic imaging examination in clinical decision-making[J]. Chin J Dig Surg, 2020, 19(4): 449-454. DOI: 10.3760/cma.j.cn115610-20200409-00241. |
| [10] |
LAI JH, LIN HH, LIN CC. Factors affecting cytological results of endoscopic ultrasound guided-fine needle aspiration during learning[J]. Diagn Pathol, 2020, 15(1): 17. DOI: 10.1186/s13000-020-00938-8. |
| [11] |
MENG HL, LI SW, SONG YL, et al. Effect of different cytopathological grading standards on the diagnosis of pancreatic cancer by endoscopic ultrasound-guided fine needle aspiration[J]. J Clin Hepatol, 2021, 37(2): 390-395. DOI: 10.3969/j.issn.1001-5256.2021.02.028. |
| [12] |
HE XJ, LIU Y, ZHANG HY, et al. Diagnosis and treatment of metastasized pancreatic tumor: A report of 25 cases[J]. Chin J Clin Oncol, 2010, 37(11): 651-653. DOI: 10.3969/j.issn.1000-8179.2010.11.015. |
| [13] |
SHIN TJ, SONG C, JEONG CW, et al. Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome[J]. J Surg Oncol, 2021, 123(1): 204-213. DOI: 10.1002/jso.26251. |
| [14] |
BROZZETTI S, BINI S, de LIO N, et al. Surgical-only treatment of pancreatic and extra-pancreatic metastases from renal cell carcinoma-quality of life and survival analysis[J]. BMC Surg, 2020, 20(1): 101. DOI: 10.1186/s12893-020-00757-0. |
| [15] |
|
| [16] |
ZHANG W, SHI J, WANG Y, et al. Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers[J]. Cancer Immunol Immunother, 2021, 70(4): 1001-1014. DOI: 10.1007/s00262-020-02745-y. |
| [17] |
LEONE P, SOLIMANDO AG, FASANO R, et al. The evolving role of immune checkpoint inhibitors in hepatocellular carcinoma treatment[J]. Vaccines (Basel), 2021, 9(5): 532. DOI: 10.3390/vaccines9050532. |
DownLoad:
